Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.

Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A.

J Hepatol. 2010 Feb;52(2):183-90. doi: 10.1016/j.jhep.2009.11.003. Epub 2009 Dec 16.

PMID:
20015567
2.
3.

Activation of natural killer cells by hepatitis C virus particles in vitro.

Farag MM, Weigand K, Encke J, Momburg F.

Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x. Epub 2011 Jun 17.

4.

Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM.

J Exp Med. 2002 Jan 7;195(1):35-41.

5.

[Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].

Pár G, Berki T, Pálinkás L, Balogh P, Szereday L, Halász M, Szekeres-Barthó J, Miseta A, Hegedus G, Mózsik G, Hunyady B, Pár A.

Orv Hetil. 2006 Apr 2;147(13):591-600. Hungarian.

PMID:
16623441
6.

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

Yoon JC, Shiina M, Ahlenstiel G, Rehermann B.

Hepatology. 2009 Jan;49(1):12-21. doi: 10.1002/hep.22624.

7.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

8.

Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.

Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, Huang L, Liu Y, Luo Y, Lu W, Zhao P, Qi Z.

PLoS One. 2011 Apr 19;6(4):e18933. doi: 10.1371/journal.pone.0018933.

9.

IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Zhang S, Saha B, Kodys K, Szabo G.

J Hepatol. 2013 Sep;59(3):442-9. doi: 10.1016/j.jhep.2013.04.022. Epub 2013 May 7.

10.

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Yoon JC, Lim JB, Park JH, Lee JM.

J Virol. 2011 Dec;85(23):12557-69. doi: 10.1128/JVI.00838-11. Epub 2011 Sep 21.

11.

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Stegmann KA, Björkström NK, Ciesek S, Lunemann S, Jaroszewicz J, Wiegand J, Malinski P, Dustin LB, Rice CM, Manns MP, Pietschmann T, Cornberg M, Ljunggren HG, Wedemeyer H.

J Infect Dis. 2012 May 1;205(9):1351-62. doi: 10.1093/infdis/jis210. Epub 2012 Mar 29.

12.

CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion.

Jang YS, Kang W, Chang DY, Sung PS, Park BC, Yoo SH, Park YW, Shin EC.

Clin Immunol. 2013 Dec;149(3):379-87. doi: 10.1016/j.clim.2013.09.007. Epub 2013 Sep 26.

PMID:
24211844
13.

Hepatitis C virus (HCV): a review of immunological aspects.

Irshad M, Khushboo I, Singh S, Singh S.

Int Rev Immunol. 2008;27(6):497-517. doi: 10.1080/08830180802432178. Review.

PMID:
19065353
14.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
15.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
16.
17.

Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.

Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, Wack A.

Eur J Immunol. 2006 Apr;36(4):919-29. Erratum in: Eur J Immunol. 2006 May;36(5):1350. Valiente, Nicholas M [corrected to Valiante, Nicholas M].

18.

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.

J Viral Hepat. 2004 Nov;11(6):519-26.

PMID:
15500552
19.

Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.

Agrati C, Nisii C, Oliva A, D'Offizi G, Montesano C, Pucillo LP, Poccia F.

Arch Immunol Ther Exp (Warsz). 2002;50(5):307-16. Review.

PMID:
12455864
20.

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.

J Immunol. 2003 Feb 1;170(3):1249-56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk